Cancer Screenings Make Comeback After Pandemic Slump, Cigna Says
(Bloomberg) -- Health insurer Cigna Corp. said the amount of preventive care received by its members during the first quarter rose to match levels seen before the pandemic began.
Cigna said it worked to drive up use of preventive services, which the company said remain suppressed nationally. Preventive care like mammographies, colonoscopies, childhood vaccinations, and cervical cancer screenings all rebounded, Cigna Chief Executive Officer David Cordani said in a call with analysts. “That's a tremendous result,” he said.
The early months of the pandemic led to widespread shutdowns of planned surgeries and routine care in the U.S. a year ago. The rebound in services like childhood immunizations and cancer screenings suggests that disruptions to health-care delivery triggered by the coronavirus are abating.
Health insurers have said that non-Covid care tended to move in the inverse direction of coronavirus cases and hospitalizations. Aggregate medical spending in the U.S. dropped in 2020 for the first time on record, according to recent estimates from the Peterson-Kaiser Family Foundation Health System Tracker.
Cigna rose as much as 2.6% as of 10:23 a.m. in New York. The shares had gained 23% this year through Thursday.
Among the most concerning trends, regular visits to detect progressive diseases like cancer dropped off sharply, raising the risk that people would be diagnosed with more severe illnesses at later stages. Cigna focused on driving patients to those and other preventive services, Cordani said.
“It's a very good thing and something that our team has worked tirelessly to try to effectuate, elevating those levels,” Cordani said.
First-quarter Covid-19 cases slowed more quickly than Cigna had anticipated, and other care increased. Cigna continues to expect coronavirus treatment and testing costs to drop and non-Covid costs to increase, executives said.
Forecast Boost
The insurer reported adjusted quarterly earnings that beat analysts' estimates and boosted its profit outlook for the year. Adjusted income from operations was $4.73 per share, above the $4.41 average of projections compiled by Bloomberg.
The health-care conglomerate projected adjusted income from operations of at least $20.20 a share for the year, a 20-cent boost from the most recent forecast. The company still expects a net negative impact of $1.25 a share from Covid-19.
Cigna's medical loss ratio, a measure of health insurance premiums paid out in medical claims, was 81.8% for the first quarter, compared with 78.3% a year ago. The company cited Covid-19 impacts and the effect of a tax change. Income in its U.S. medical benefits business fell compared to a year earlier.
Its first-quarter earnings results were led by the company's Evernorth health services segment, in which both revenue and income grew by 13% year-over-year. The company's pharmacy benefits business, part of Evernorth, added 2.2 million customers in the quarter to reach 101 million. Total pharmacy prescriptions filled increased by 9%.
Overall adjusted operating income in the quarter fell slightly, to $1.7 billion, compared with $1.8 billion a year ago.
©2021 Bloomberg L.P.
-
One El Nino, India Can Handle. Two Could Break The Granary
India's grain stocks can absorb one bad year, but a second El Nino could drain the buffer in two to three years, economists say.
-
India's Troika Of Good Luck | Joining The Dots
As Jensen Huang's exit drags Nvidia down, a cooling AI trade and resilient earnings have revived investor interest in India. A likely RBI rate hike looms.
-
Talking Points This Week: Leadership Shock At Nvidia, Earnings Strength, And The Fog Over Hormuz
The Anthropic IPO pricing and first trading day, Nvidia's upcoming earnings, and any fresh signals from Iran will set the tone for the following week.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.